Advertisement
Screener

LIFECORE BIOMEDICAL, INC. (LFCR) Depreciation and Amortization

2.8 / 5 stars · 68/120 Roast Me

LIFECORE BIOMEDICAL, INC. Depreciation and Amortization

LIFECORE BIOMEDICAL, INC. (LFCR) reported Depreciation and Amortization of $1.98 million for the 3-month period ending 2025-09-30, per its 10-Q filed 2025-11-06.

Financial Statements › Cash Flow › Operating Activities

us-gaap:DepreciationDepletionAndAmortization · last filed 2025-11-06

  • LIFECORE BIOMEDICAL, INC. depreciation, depletion and amortization for the quarter ending 2025-09-30 was $1.98M.
  • LIFECORE BIOMEDICAL, INC. depreciation, depletion and amortization for the quarter ending 2025-05-25 was $1.91M, a 4.97% decline year-over-year.
  • LIFECORE BIOMEDICAL, INC. depreciation, depletion and amortization for the quarter ending 2025-02-23 was $2.08M, a 3.49% increase year-over-year.
  • LIFECORE BIOMEDICAL, INC. depreciation, depletion and amortization for the quarter ending 2024-11-24 was $2.04M, a 15.74% increase year-over-year.
  • LIFECORE BIOMEDICAL, INC. depreciation, depletion and amortization for fiscal 2025 was $8.03M, a 0.92% increase from fiscal 2024.
  • LIFECORE BIOMEDICAL, INC. depreciation, depletion and amortization for fiscal 2024 was $7.95M, a 39.64% decline from fiscal 2023.
  • LIFECORE BIOMEDICAL, INC. depreciation, depletion and amortization for fiscal 2023 was $13.18M, a 27.04% decline from fiscal 2022.
  • LIFECORE BIOMEDICAL, INC. depreciation, depletion and amortization for fiscal 2022 was $18.06M, a 9.09% decline from fiscal 2021.
Period endDepreciation, Depletion and Amortization 3 monthDepreciation, Depletion and Amortization 3 month as first filedDepreciation, Depletion and Amortization 6 monthDepreciation, Depletion and Amortization 6 month as first filedDepreciation, Depletion and Amortization 9 monthDepreciation, Depletion and Amortization 9 month as first filedDepreciation, Depletion and Amortization 12 monthDepreciation, Depletion and Amortization 12 month as first filed
2025-09-30$1.98M
10-Q · filed 2025-11-06
2025-05-25$1.91M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-08-07
$3.99M
derived: sum of 2 quarters · filed 2025-08-07
$6.03M
derived: sum of 3 quarters · filed 2025-08-07
$8.03M
10-K · filed 2025-08-07
2025-02-23$2.08M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-04-03
$4.12M
derived: sum of 2 quarters · filed 2025-04-03
$6.11M
10-Q · filed 2025-04-03
$8.13M
derived: sum of 4 quarters · filed 2025-11-06
2024-11-24$2.04M
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-01-02
$4.04M
10-Q · filed 2025-01-02
$6.05M
derived: sum of 3 quarters · filed 2025-11-06
$8.06M
derived: sum of 4 quarters · filed 2025-11-06
2024-08-25$1.99M
10-Q · filed 2025-11-06
$4.01M
derived: sum of 2 quarters · filed 2025-11-06
$6.01M
derived: sum of 3 quarters · filed 2025-11-06
$7.78M
derived: sum of 4 quarters · filed 2025-11-06
2024-05-26$2.01M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-08-07
$4.02M
derived: sum of 2 quarters · filed 2025-08-07
$5.79M
derived: sum of 3 quarters · filed 2025-08-07
$7.95M
10-K · filed 2025-08-07
$8.86M
10-K · filed 2024-08-26
2024-02-25$2.01M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-04-03
$3.77M
derived: sum of 2 quarters · filed 2025-04-03
$5.94M
10-Q · filed 2025-04-03
$6.61M
10-Q · filed 2024-08-09
$8.61M
derived: sum of 4 quarters · filed 2025-04-03
2023-11-26$1.77M
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-01-02
$3.93M
10-Q · filed 2025-01-02
$4.37M
10-Q · filed 2024-08-09
$6.60M
derived: sum of 3 quarters · filed 2025-01-02
$9.82M
derived: sum of 4 quarters · filed 2025-01-02
2023-08-27$2.17M
10-Q · filed 2024-10-04
$4.84M
derived: sum of 2 quarters · filed 2024-10-04
$8.05M
derived: sum of 3 quarters · filed 2024-10-04
$10.99M
derived: sum of 4 quarters · filed 2024-10-04
2023-05-28$2.67M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-08-26
$5.88M
derived: sum of 2 quarters · filed 2024-08-26
$8.82M
derived: sum of 3 quarters · filed 2024-08-26
$13.18M
10-K · filed 2024-08-26
$13.29M
10-K · filed 2024-03-20
2023-02-26$3.21M
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-08-09
$6.15M
derived: sum of 2 quarters · filed 2024-08-09
$10.51M
10-Q · filed 2024-08-09
$10.39M
10-Q · filed 2023-06-02
$14.02M
derived: sum of 4 quarters · filed 2024-08-26
2022-11-27$2.94M
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09
$7.29M
10-Q · filed 2024-08-09
$7.24M
10-Q · filed 2023-03-16
$10.81M
derived: sum of 3 quarters · filed 2024-08-26
$14.36M
derived: sum of 4 quarters · filed 2024-08-26
2022-08-28$4.35M
10-Q · filed 2024-08-09
$5.01M
10-Q · filed 2022-10-07
$7.87M
derived: sum of 2 quarters · filed 2024-08-26
$11.42M
derived: sum of 3 quarters · filed 2024-08-26
$17.35M
derived: sum of 4 quarters · filed 2024-08-26
2022-05-29$3.51M
derived: 10-K 12 month − 10-K 9 month · filed 2024-08-26
$7.07M
derived: sum of 2 quarters · filed 2024-08-26
$13.00M
derived: sum of 3 quarters · filed 2024-08-26
$18.06M
10-K · filed 2024-08-26
$17.88M
10-K · filed 2022-09-14
2022-02-27$3.55M
derived: 10-K 9 month − 10-K 6 month · filed 2024-03-20
$9.48M
derived: sum of 2 quarters · filed 2024-03-20
$14.55M
10-K · filed 2024-03-20
$14.49M
10-Q · filed 2022-04-07
$19.61M
derived: sum of 4 quarters · filed 2024-03-20
2021-11-28$5.93M
derived: 10-K 6 month − 10-K 3 month · filed 2024-03-20
$10.99M
10-K · filed 2024-03-20
$10.96M
10-Q · filed 2022-01-07
$16.05M
derived: sum of 3 quarters · filed 2024-03-20
$21.04M
derived: sum of 4 quarters · filed 2024-03-20
2021-08-29$5.07M
10-K · filed 2024-03-20
$5.05M
10-Q · filed 2021-10-05
$10.12M
derived: sum of 2 quarters · filed 2024-03-20
$15.11M
derived: sum of 3 quarters · filed 2024-03-20
$19.83M
derived: sum of 4 quarters · filed 2024-03-20
2021-05-30$5.06M
derived: 10-K 12 month − 10-K 9 month · filed 2024-03-20
$10.04M
derived: sum of 2 quarters · filed 2024-03-20
$14.77M
derived: sum of 3 quarters · filed 2024-03-20
$19.87M
10-K · filed 2024-03-20
2021-02-28$4.98M
derived: 10-K 9 month − 10-Q 6 month · filed 2024-03-20
$9.71M
derived: sum of 2 quarters · filed 2024-03-20
$14.81M
10-K · filed 2024-03-20
$19.85M
derived: sum of 4 quarters · filed 2024-03-20
2020-11-29$4.72M
derived: 10-Q 6 month − 10-K 3 month · filed 2022-01-07
$9.83M
10-Q · filed 2022-01-07
$14.86M
derived: sum of 3 quarters · filed 2024-03-20
$19.63M
derived: sum of 4 quarters · filed 2024-03-20
2020-08-30$5.10M
10-K · filed 2024-03-20
$10.14M
derived: sum of 2 quarters · filed 2024-03-20
$14.91M
derived: sum of 3 quarters · filed 2024-03-20
$19.44M
derived: sum of 4 quarters · filed 2024-03-20
2020-05-31$5.04M
derived: 10-K/A 12 month − 10-Q 9 month · filed 2023-03-16
$9.81M
derived: sum of 2 quarters · filed 2023-03-16
$14.34M
derived: sum of 3 quarters · filed 2023-03-16
$18.84M
10-K/A · filed 2023-03-16
2020-02-23$4.77M
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-04-08
$9.30M
derived: sum of 2 quarters · filed 2021-04-08
$13.80M
10-Q · filed 2021-04-08
$18.52M
derived: sum of 4 quarters · filed 2021-07-29
2019-11-24$4.53M
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-01-07
$9.03M
10-Q · filed 2021-01-07
$13.75M
derived: sum of 3 quarters · filed 2021-07-29
$17.80M
derived: sum of 4 quarters · filed 2021-07-29
2019-08-25$4.50M
10-Q · filed 2020-10-07
$9.23M
derived: sum of 2 quarters · filed 2021-07-29
$13.28M
derived: sum of 3 quarters · filed 2021-07-29
$16.59M
derived: sum of 4 quarters · filed 2021-07-29
2019-05-26$4.72M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-07-29
$8.77M
derived: sum of 2 quarters · filed 2021-07-29
$12.09M
derived: sum of 3 quarters · filed 2021-07-29
$15.23M
10-K · filed 2021-07-29
2019-02-24$4.05M
10-Q · filed 2019-04-04
$7.36M
derived: sum of 2 quarters · filed 2019-04-04
$10.51M
10-Q · filed 2020-04-03
$13.84M
derived: sum of 4 quarters · filed 2020-08-14
2018-11-25$3.31M
10-Q · filed 2019-01-07
$6.46M
10-Q · filed 2020-01-02
$9.79M
derived: sum of 3 quarters · filed 2020-08-14
$12.94M
derived: sum of 4 quarters · filed 2020-08-14
2018-08-26$3.15M
10-Q · filed 2019-10-03
$6.48M
derived: sum of 2 quarters · filed 2020-08-14
$9.62M
derived: sum of 3 quarters · filed 2020-08-14
$12.60M
derived: sum of 4 quarters · filed 2020-08-14
2018-05-27$3.34M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-08-14
$6.48M
derived: sum of 2 quarters · filed 2020-08-14
$9.46M
derived: sum of 3 quarters · filed 2020-08-14
$12.41M
10-K · filed 2020-08-14
2018-02-25$3.14M
10-Q · filed 2019-04-04
$6.12M
derived: sum of 2 quarters · filed 2019-04-04
$9.08M
10-Q · filed 2019-04-04
$11.93M
derived: sum of 4 quarters · filed 2019-08-01
2017-11-26$2.98M
10-Q · filed 2019-01-07
$5.93M
10-Q · filed 2019-01-07
$8.78M
derived: sum of 3 quarters · filed 2019-08-01
$11.50M
derived: sum of 4 quarters · filed 2019-08-01
2017-08-27$2.95M
10-Q · filed 2018-10-05
$5.80M
derived: sum of 2 quarters · filed 2019-08-01
$8.52M
derived: sum of 3 quarters · filed 2019-08-01
$11.07M
derived: sum of 4 quarters · filed 2019-08-01
2017-05-28$2.85M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-08-01
$5.57M
derived: sum of 2 quarters · filed 2019-08-01
$8.12M
derived: sum of 3 quarters · filed 2019-08-01
$10.68M
10-K · filed 2019-08-01
2017-02-26$2.72M
10-Q · filed 2018-04-05
$5.27M
derived: sum of 2 quarters · filed 2018-04-05
$7.83M
10-Q · filed 2018-04-05
$10.73M
derived: sum of 4 quarters · filed 2018-08-09
2016-11-27$2.55M
10-Q · filed 2018-01-05
$2.56M
10-Q · filed 2017-01-05
$5.11M
10-Q · filed 2018-01-05
$8.01M
derived: sum of 3 quarters · filed 2018-08-09
$10.16M
derived: sum of 4 quarters · filed 2018-08-09
2016-08-28$2.55M
10-Q · filed 2017-09-28
$5.46M
derived: sum of 2 quarters · filed 2018-08-09
$7.61M
derived: sum of 3 quarters · filed 2018-08-09
$9.73M
derived: sum of 4 quarters · filed 2018-08-09
2016-05-29$2.91M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-08-09
$5.06M
derived: sum of 2 quarters · filed 2018-08-09
$7.18M
derived: sum of 3 quarters · filed 2018-08-09
$9.39M
10-K · filed 2018-08-09
2016-02-28$2.15M
10-Q · filed 2017-04-07
$4.28M
derived: sum of 2 quarters · filed 2017-04-07
$6.49M
10-Q · filed 2017-04-07
$8.40M
derived: sum of 4 quarters · filed 2018-03-15
2015-11-29$2.13M
10-Q · filed 2017-01-05
$4.34M
10-Q · filed 2017-01-05
$6.25M
derived: sum of 3 quarters · filed 2018-03-15
$8.09M
derived: sum of 4 quarters · filed 2018-03-15
2015-08-30$2.21M
10-Q · filed 2016-09-29
$4.12M
derived: sum of 2 quarters · filed 2018-03-15
$5.96M
derived: sum of 3 quarters · filed 2018-03-15
$7.79M
derived: sum of 4 quarters · filed 2018-03-15
2015-05-31$1.91M
derived: 10-K/A 12 month − 10-Q 9 month · filed 2018-03-15
$3.75M
derived: sum of 2 quarters · filed 2018-03-15
$5.58M
derived: sum of 3 quarters · filed 2018-03-15
$7.09M
10-K/A · filed 2018-03-15
2015-03-01$1.83M
10-Q · filed 2016-03-30
$3.66M
derived: sum of 2 quarters · filed 2016-03-30
$5.18M
10-Q · filed 2016-03-30
$6.93M
derived: sum of 4 quarters · filed 2016-08-01
2014-11-30$1.83M
10-Q · filed 2016-01-07
$3.34M
10-Q · filed 2016-01-07
$5.09M
derived: sum of 3 quarters · filed 2016-08-01
$6.67M
derived: sum of 4 quarters · filed 2016-08-01
2014-08-31$1.51M
10-Q · filed 2015-10-01
$3.26M
derived: sum of 2 quarters · filed 2016-08-01
$4.84M
derived: sum of 3 quarters · filed 2016-08-01
$6.79M
derived: sum of 4 quarters · filed 2016-08-01
2014-05-25$1.75M
derived: 10-K 12 month − 10-Q 9 month · filed 2016-08-01
$3.33M
derived: sum of 2 quarters · filed 2016-08-01
$5.27M
derived: sum of 3 quarters · filed 2016-08-01
$7.11M
10-K · filed 2016-08-01
2014-02-23$1.58M
10-Q · filed 2015-04-02
$3.52M
derived: sum of 2 quarters · filed 2015-04-02
$5.36M
10-Q · filed 2015-04-02
$7.13M
derived: sum of 4 quarters · filed 2015-04-02
2013-11-24$1.95M
10-Q · filed 2015-01-09
$3.79M
10-Q · filed 2015-01-09
$5.55M
derived: sum of 3 quarters · filed 2015-01-09
2013-08-25$1.84M
10-Q · filed 2014-10-08
$3.61M
derived: sum of 2 quarters · filed 2014-10-08
2013-05-28$1.77M
derived: 10-K 12 month − 10-Q 9 month · filed 2014-08-01
$7.29M
10-K · filed 2014-08-01
2013-05-26$1.77M
derived: 10-K 12 month − 10-Q 9 month · filed 2015-07-31
$3.63M
derived: sum of 2 quarters · filed 2015-07-31
$5.44M
derived: sum of 3 quarters · filed 2015-07-31
$7.29M
10-K · filed 2015-07-31
2013-02-24$1.87M
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-03-28
$3.67M
derived: sum of 2 quarters · filed 2014-03-28
$5.53M
10-Q · filed 2014-03-28
$7.04M
derived: sum of 4 quarters · filed 2014-08-01
2012-11-25$1.80M
derived: 10-Q 6 month − 10-Q 3 month · filed 2014-01-03
$3.66M
10-Q · filed 2014-01-03
$5.17M
derived: sum of 3 quarters · filed 2014-08-01
$6.55M
derived: sum of 4 quarters · filed 2014-08-01
2012-08-26$1.86M
10-Q · filed 2013-09-26
$3.37M
derived: sum of 2 quarters · filed 2014-08-01
$4.75M
derived: sum of 3 quarters · filed 2014-08-01
$6.12M
derived: sum of 4 quarters · filed 2014-08-01
2012-05-27$1.51M
derived: 10-K 12 month − 10-Q 9 month · filed 2014-08-01
$2.89M
derived: sum of 2 quarters · filed 2014-08-01
$4.27M
derived: sum of 3 quarters · filed 2014-08-01
$5.62M
10-K · filed 2014-08-01
2012-02-26$1.38M
derived: 10-Q 9 month − 10-Q 6 month · filed 2013-04-04
$2.76M
derived: sum of 2 quarters · filed 2013-04-04
$4.11M
10-Q · filed 2013-04-04
$5.51M
derived: sum of 4 quarters · filed 2013-08-07
2011-11-27$1.37M
derived: 10-Q 6 month − 10-Q/A 3 month · filed 2013-01-04
$2.73M
10-Q · filed 2013-01-04
$4.13M
derived: sum of 3 quarters · filed 2013-08-07
2011-08-28$1.35M
10-Q/A · filed 2013-01-02
$2.76M
derived: sum of 2 quarters · filed 2013-08-07
2011-05-29$1.40M
derived: 10-K 12 month − 10-Q 9 month · filed 2013-08-07
$5.31M
10-K · filed 2013-08-07
2011-02-27$3.91M
10-Q · filed 2012-03-28
2010-11-28$2.60M
10-Q · filed 2012-01-05
2010-08-29$1.31M
10-Q · filed 2011-10-05
2010-05-30$3.36M
10-K · filed 2012-08-08

Similar stocks

Stock NameCountryMarket CapPE Ratio
ADC Therapeutics SA (ADCT)$0.163B-1.39
Minerva Neurosciences, Inc. (NERV)United States$0.165B-0.66
Tonix Pharmaceuticals Holding Corp. (TNXP)United States$0.166B-1.34
Annexon, Inc. (ANNX)United States$0.147B-4.22
Corbus Pharmaceuticals Holdings, Inc. (CRBP)United States$0.144B-1.72
Organogenesis Holdings Inc. (ORGO)United States$0.182B-3.70
SPRUCE BIOSCIENCES, INC. (SPRB)United States$0.142B-2.89
Korro Bio, Inc. (KRRO)United States$0.141B-1.81
AN2 Therapeutics, Inc. (ANTX)United States$0.185B-4.84
Atrium Therapeutics, Inc. (RNA)United States$0.140B